Antibiotic resistance in Pseudomonas aeruginosa–Mechanisms, epidemiology and evolution

J Botelho, F Grosso, L Peixe - Drug resistance updates, 2019 - Elsevier
Antibiotics are powerful drugs used in the treatment of bacterial infections. The inappropriate
use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …

The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria

D Hammoudi Halat, C Ayoub Moubareck - Antibiotics, 2020 - mdpi.com
Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …

The epidemiology of carbapenemases in Latin America and the Caribbean

K Escandón-Vargas, S Reyes, S Gutiérrez… - Expert review of anti …, 2017 - Taylor & Francis
ABSTRACT Introduction: Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp.
infections are major causes of morbidity and mortality, especially due to the emergence and …

Structural and functional aspects of class A carbapenemases

T Naas, L Dortet, BI Iorga - Current drug targets, 2016 - ingentaconnect.com
The fight against infectious diseases is probably one of the greatest public health challenges
faced by our society, especially with the emergence of carbapenem-resistant gram …

Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods

AE Laudy, P Rog, K Smolińska-Król, M Ćmiel… - PloS one, 2017 - journals.plos.org
Knowledge of the prevalence of ESBL enzymes among P. aeruginosa strains compared to
the Enterobacteraiceae family is limited. The phenotypic tests recommended by EUCAST for …

[PDF][PDF] The intriguing carbapenemases of Pseudomonas aeruginosa: Current status, genetic profile, and global epidemiology

DH Halat, CA Moubareck - Yale J. Biol. Med, 2022 - pdfs.semanticscholar.org
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

High prevalence of antimicrobial resistance among gram-negative isolated bacilli in intensive care units at a tertiary-care hospital in Yucatán Mexico

AH Uc-Cachón, C Gracida-Osorno, IG Luna-Chi… - Medicina, 2019 - mdpi.com
Background and Objectives: Antimicrobial resistance (AMR) is increasing worldwide and
imposes significant life-threatening risks to several different populations, especially to those …

In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results …

JA Karlowsky, KM Kazmierczak… - Antimicrobial agents …, 2018 - Am Soc Microbiol
The in vitro activities of ceftazidime-avibactam and comparators against 9,149 isolates of
Enterobacteriaceae and 2,038 isolates of Pseudomonas aeruginosa collected by 42 …

Antimicrobial resistance in Romania: updates on gram-negative ESCAPE pathogens in the clinical, veterinary, and aquatic sectors

IC Barbu, I Gheorghe-Barbu, GA Grigore… - International Journal of …, 2023 - mdpi.com
Multidrug-resistant Gram-negative bacteria such as Acinetobacter baumannii,
Pseudomonas aeruginosa, and members of the Enterobacterales order are a challenging …

The collateral effects of COVID-19 pandemic on the status of carbapenemase-producing pathogens

C Ayoub Moubareck… - Frontiers in Cellular and …, 2022 - frontiersin.org
The serious challenge of antimicrobial resistance continues to threaten public health and
lingers in the era of the coronavirus disease 2019 (COVID-19), declared pandemic by the …